Jazz Pharmaceuticals (JAZZ) Enterprise Value (2010 - 2026)
Jazz Pharmaceuticals' quarterly Enterprise Value came in at -$1.8 billion in Q1 2026, up 0.95% year-on-year from -$1.8 billion in Q1 2025, and down 32.5% quarter-over-quarter from -$1.4 billion in Q4 2025.
Jazz Pharmaceuticals has reported Enterprise Value for 17 years, with the latest figure at -$1.8 billion in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 0.95% year-over-year to -$1.8 billion; the trailing twelve-month figure through Mar 2026 stood at -$1.8 billion (up 0.95% YoY), and the FY2025 full-year result was -$1.4 billion, up 42.31% from the prior year.
- Enterprise Value for Q1 2026 stood at -$1.8 billion, down from -$1.4 billion in the prior quarter.
- The five-year high for Enterprise Value was -$490.8 million in Q1 2022, with the low at -$2.4 billion in Q4 2024.
- Average Enterprise Value over 5 years is -$1.4 billion, with a median of -$1.3 billion recorded in 2023.
- Year-over-year, Enterprise Value jumped 76.6% in 2022 and tumbled 137.94% in 2023.
- Tracing JAZZ's Enterprise Value over 5 years: stood at -$881.5 million in 2022, then sank by 70.88% to -$1.5 billion in 2023, then slumped by 60.18% to -$2.4 billion in 2024, then soared by 42.31% to -$1.4 billion in 2025, then tumbled by 32.5% to -$1.8 billion in 2026.
- The last three Enterprise Value figures came in at -$1.8 billion (Q1 2026), -$1.4 billion (Q4 2025), and -$1.3 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn | -1.84 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.84 Bn |
| Dec 31, 2025 | -1.39 Bn |
| Sep 30, 2025 | -1.33 Bn |
| Jun 30, 2025 | -1.19 Bn |
| Mar 31, 2025 | -1.86 Bn |
| Dec 31, 2024 | -2.41 Bn |
| Sep 30, 2024 | -2.22 Bn |
| Jun 30, 2024 | -1.36 Bn |
| Mar 31, 2024 | -1.44 Bn |
| Dec 31, 2023 | -1.51 Bn |
| Sep 30, 2023 | -1.34 Bn |
| Jun 30, 2023 | -1.28 Bn |
| Mar 31, 2023 | -1.17 Bn |
| Dec 31, 2022 | -881.48 Mn |
| Sep 30, 2022 | -839.36 Mn |
| Jun 30, 2022 | -711.27 Mn |
| Mar 31, 2022 | -490.84 Mn |
| Dec 31, 2021 | -591.45 Mn |
| Sep 30, 2021 | -671.78 Mn |
| Jun 30, 2021 | -891.40 Mn |
| Mar 31, 2021 | -2.10 Bn |
| Dec 31, 2020 | -1.06 Bn |
| Sep 30, 2020 | -741.94 Mn |
| Jun 30, 2020 | -786.08 Mn |
| Mar 31, 2020 | -701.60 Mn |
| Dec 31, 2019 | -637.34 Mn |
| Sep 30, 2019 | -795.18 Mn |
| Jun 30, 2019 | -637.74 Mn |
| Mar 31, 2019 | -547.47 Mn |
| Dec 31, 2018 | -309.62 Mn |
| Sep 30, 2018 | -499.02 Mn |
| Jun 30, 2018 | -485.08 Mn |
| Mar 31, 2018 | -453.17 Mn |
| Dec 31, 2017 | -386.04 Mn |
| Sep 30, 2017 | -452.62 Mn |
| Jun 30, 2017 | -319.21 Mn |
| Mar 31, 2017 | -407.00 Mn |
| Dec 31, 2016 | -425.96 Mn |
| Sep 30, 2016 | -425.99 Mn |
| Jun 30, 2016 | -916.38 Mn |
| Mar 31, 2016 | -980.54 Mn |
| Dec 31, 2015 | -988.79 Mn |
| Sep 30, 2015 | -998.85 Mn |
| Jun 30, 2015 | -921.59 Mn |
| Mar 31, 2015 | -782.55 Mn |
| Dec 31, 2014 | -683.98 Mn |
| Sep 30, 2014 | -574.95 Mn |
| Jun 30, 2014 | -267.86 Mn |
| Mar 31, 2014 | -228.26 Mn |
| Dec 31, 2013 | -636.50 Mn |
| Sep 30, 2013 | -588.46 Mn |
| Jun 30, 2013 | -504.31 Mn |
| Mar 31, 2013 | -450.51 Mn |
| Dec 31, 2012 | -387.20 Mn |
| Sep 30, 2012 | -189.79 Mn |
| Jun 30, 2012 | -154.54 Mn |
| Mar 31, 2012 | -244.22 Mn |
| Dec 31, 2011 | -157.90 Mn |
| Sep 30, 2011 | -113.35 Mn |
| Jun 30, 2011 | -102.40 Mn |
| Mar 31, 2011 | -65.06 Mn |
| Dec 31, 2010 | -44.79 Mn |
| Sep 30, 2010 | -22.85 Mn |
| Jun 30, 2010 | -9.57 Mn |